Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah L Zink

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Chemical Society|August 14, 2008
Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347Chaowei Zhang, James Occi, Prakash Masurekar, et al.
The Journal of Antibiotics|July 29, 2010
Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profilingMichael A Goetz, Chaowei Zhang, Deborah L Zink, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activitiesSheo B Singh, Michael A Goetz, Scott K Smith, et al.
The Journal of Antibiotics|April 3, 2014
Isolation, structure elucidation and antibacterial activity of a new tetramic acid, ascosetinJohn G Ondeyka, Scott K Smith, Deborah L Zink, et al.
The Journal of Antibiotics|October 6, 2007
Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosaHiranthi Jayasuriya, Kithsiri Herath, John G Ondeyka, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Cell Chemical Biology|October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Chemical Society|August 14, 2008
Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347Chaowei Zhang, James Occi, Prakash Masurekar, et al.
The Journal of Antibiotics|July 29, 2010
Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profilingMichael A Goetz, Chaowei Zhang, Deborah L Zink, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2012
Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activitiesSheo B Singh, Michael A Goetz, Scott K Smith, et al.
The Journal of Antibiotics|April 3, 2014
Isolation, structure elucidation and antibacterial activity of a new tetramic acid, ascosetinJohn G Ondeyka, Scott K Smith, Deborah L Zink, et al.
The Journal of Antibiotics|October 6, 2007
Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosaHiranthi Jayasuriya, Kithsiri Herath, John G Ondeyka, et al.
Chemistry & Biology|August 27, 2011
Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureusJohn W Phillips, Michael A Goetz, Scott K Smith, et al.
Cell Chemical Biology|October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Pageof 5